About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Molecular Medical Imaging research group focuses its activity on deepening the molecular bases and developing new areas of research in molecular signaling pathways and the identification of new theranostic targets.
We promote the confluence of basic and clinical researchers, experts in imaging and molecular biology to provide:
In this context, the creation of a translational imaging unit constitutes a basic objective for the development of research aimed at the personalized treatment of patients.
The group is made up of medical specialists in molecular imaging, chemists and pharmacists specializing in tracer synthesis, and biomedical engineers and physicists specializing in image processing and tomography equipment. These are affiliated with different institutions, such as the Vall d'Hebron Research Institute (VHIR), the Vall d'Hebron University Hospital (HUVH) and the Institute of Diagnostic Imaging (IDI).
IP: José Raul Herance Camacho Collaborators: Fiorella Dellepiane Clarke, Joan Castell Conesa, Santiago Aguade Bruix, Carina Espinet Coll, Nuria Roson Gradaille, Carolina Aparicio Gomez, Alberto Roque Pérez, Mònica Velasco Nuño, Julia Baguña Torres, Irene Hernández Hernández, Maria Nazarena Pizzi Funding agency: Instituto de Salud Carlos III Funding: 159720 Reference: PI20/01588 Duration: 01/01/2021 - 30/06/2025
IP: Marta Martínez Vicente Collaborators: José Antonio Arranz Amo, Jorge Hernández Vara, Eddie Pradas Gracia, Guillem Pintos Morell, Clara Carnicer Cáceres, Carles Lorenzo Bosquet, David Moreno Martinez, Jordi Riera Heredia, Marta Montpeyó Garcia-Moreno, Daniela Samaniego Toro, Laura Castillo Ribelles Funding agency: Instituto de Salud Carlos III Funding: 245932.5 Reference: PI20/00728 Duration: 01/01/2021 - 30/06/2025
IP: Andreea Ciudin Mihai Collaborators: Oscar González López, Fiorella Ximena Palmas Candia, Marina Giralt Arnaiz, Marta Comas Martínez, Rosa Burgos Peláez, Irene Hernández Hernández, Enzamaría Fidilio Meli, Efráin Santiago Cordero Vázquez, Cristina Gamez Cenzano Funding agency: Instituto de Salud Carlos III Funding: 123420 Reference: PI20/01086 Duration: 01/01/2021 - 31/12/2024
IP: Jordi Bove Badell Collaborators: Miquel Vila Bover, Alejandro Ferré Masó, Oriol de Fabregues-Boixar Nebot, Carles Lorenzo Bosquet, Thais Cuadros Arasa, Antonio Palasi Franco, David Ramos Vicente, Mariona Marchena Herrera Funding agency: Instituto de Salud Carlos III Funding: 165770 Reference: PI21/01358 Duration: 01/01/2022 - 31/12/2024
PMID: 34999818 Journal: European Heart Journal-Cardiovascular Imaging Year: 2022 Reference: Eur Heart J Cardiovasc Imaging. 2022 Jan 6. pii: 6498863. doi: 10.1093/ehjci/jeab279. Impact factor: 6.875 Publication type: Paper in international publication Authors: Escobar, Manuel, Roque, Albert, Pizzi, Maria N, Fernandez-Hidalgo, Nuria, Romero-Farina, Guillermo, Burcet, Gemma, Reyes-Juarez, Jose Luis, Espinet, Carina, Castell-Conesa, Joan, Cuellar-Calabria, Hug et al. DOI: 10.1093/ehjci/jeab279
PMID: 34794916 Journal: Revista Espanola de Medicina Nuclear e Imagen Molecular Year: 2022 Reference: Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Jan-Feb;41(1):52-54. doi: 10.1016/j.remnie.2021.05.002. Epub 2021 Nov 16. Impact factor: 1.359 Publication type: Letter or abstract Authors: Carrillo-Villamizar, E, Cardozo-Saavedra, A, Lorenzo-Bosquet, C, Lucas Del Pozo, S, Martinez-Saez, E, Hernandez-Vara, J et al. DOI: 10.1016/j.remnie.2021.05.002
PMID: 33630792 Journal: CLINICAL NUCLEAR MEDICINE Year: 2021 Reference: Clin Nucl Med. 2021 Jun 1;46(6):e307-e311. doi: 10.1097/RLU.0000000000003537. Impact factor: 7.794 Publication type: Paper in international publication Authors: Orozco-Galvez, Olimpia, Fernandez-Codina, Andreu, Simo-Perdigo, Marc, Pinal-Fernandez, Iago, Martinez-Valle, Fernando et al. DOI: 10.1097/RLU.0000000000003537
PMID: 33612278 Journal: Radiologia Year: 2021 Reference: Radiologia (Engl Ed). 2021 Feb 18. pii: S0033-8338(21)00028-X. doi: 10.1016/j.rx.2020.12.007. Impact factor: 0 Publication type: Paper in national publication Authors: Roson Gradaille, N, Narbona Diez, A, Garriga Farriol, M V, Pruna Comella, X, Pedraza Gutierrez, S, Lopez Cano, M, Badia, J M et al. DOI: 10.1016/j.rx.2020.12.007
PMID: 33610494 Journal: Revista Espanola de Medicina Nuclear e Imagen Molecular Year: 2021 Reference: Rev Esp Med Nucl Imagen Mol. 2021 Mar-Apr;40(2):69-71. doi: 10.1016/j.remn.2021.01.004. Epub 2021 Feb 18. Impact factor: 1.359 Publication type: Editorial in national publication Authors: Garcia-Burillo, A et al. DOI: 10.1016/j.remn.2021.01.004
PMID: 32909055 Journal: EUROPEAN RADIOLOGY Year: 2021 Reference: Eur Radiol. 2021 Mar;31(3):1460-1470. doi: 10.1007/s00330-020-07174-0. Epub 2020 Sep 9. Impact factor: 5.315 Publication type: Paper in international publication Authors: Jordi-Ollero, Olivia, Ligero, Marta, Delgado-Munoz, Eric, Leiva, David, Mast, Richard, Suarez, Cristina, Sala-Llonch, Roser, Calvo, Nahum, Escobar, Manuel, Navarro-Martin, Arturo et al. DOI: 10.1007/s00330-020-07174-0
PMID: 29154283 Journal: JOURNAL OF ALZHEIMERS DISEASE Year: 2018 Reference: J Alzheimers Dis. 2018;61(1):321-332. doi: 10.3233/JAD-170693. Impact factor: 3.476 Publication type: Paper in international publication Authors: Guzman-de-Villoria, Juan A, Cuberas-Borros, Gemma, Roca, Isabel, Boada, Merce, Tarraga, Lluis, Hernandez, Isabel, Buendia, Mar, Rubio, Lourdes, Torres, Gustavo, Bittini, Angel et al. DOI: 10.3233/JAD-170693
PMID: 28249725 Journal: JOINT BONE SPINE Year: 2018 Reference: Joint Bone Spine. 2018 Jan;85(1):119. doi: 10.1016/j.jbspin.2017.02.008. Epub 2017 Feb 27. Impact factor: 3.304 Publication type: Paper in international publication Authors: Fernandez-Codina, Andreu, Simo, Marc, Solans-Laque, Roser, Martinez-Valle, Fernando et al. DOI: 10.1016/j.jbspin.2017.02.008
The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.
Phase IV AI is included in the Horizon Europe programme, lasts 3 years and prioritises data security and privacy compliance.
YSOTOPE, a DeepTech start-up with the mission to improve the use of immunotherapies through medical imaging, became part of the spin-off network of VHIR and successfully closed its first investment round of €150,000 with Biozell Ventures.
